A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value Seeking Alpha
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents - GEN - Genetic Engineering and Biotechnology News
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents GEN - Genetic Engineering and Biotechnology News
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents - GEN - Genetic Engineering and Biotechnology News
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents GEN - Genetic Engineering and Biotechnology News
Illumina’s high-throughput single-cell CRISPR prep makes gene editing a reality - Illumina
Illumina Director of Systems Integration Carolyn Conant presents the poster at AGBT 2025. February 25, 2025 🖨 View this article as a printable PDF 🔈 Listen to this ar...
Illumina Single Cell 3' RNA Prep Kits | Scalable scRNA-Seq library prep - Illumina
Illumina Single Cell 3' RNA Prep Kits | Scalable scRNA-Seq library prep Illumina
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page